| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |